piracetam has been researched along with vitamin k semiquinone radical in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Col-Debeys, C; Crasborn, L; Lavenne-Pardonge, E; Moriau, M; von Frenckell, R | 1 |
1 trial(s) available for piracetam and vitamin k semiquinone radical
Article | Year |
---|---|
The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants.
Topics: Adult; Anticoagulants; Biomarkers; Blood Coagulation Tests; Blood Viscosity; Dipyridamole; Drug Therapy, Combination; Female; Hemorheology; Heparin; Humans; Male; Middle Aged; Pentoxifylline; Piracetam; Platelet Aggregation Inhibitors; Pyrrolidines; Recurrence; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Venous Thrombosis; Vitamin K | 1995 |
1 other study(ies) available for piracetam and vitamin k semiquinone radical
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |